Discovery Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,986,643
Closed -$540M 136
2015
Q3
$540M Buy
1,986,643
+1,065,550
+116% +$327M 6% 1
2015
Q2
$280M Sell
921,093
-19,125
-2% -$5.7M 3.29% 7
2015
Q1
$280M Buy
940,218
+117,682
+14% +$33.6M 3.19% 9
2014
Q4
$212M Sell
822,536
-1,000,250
-55% -$250M 2.18% 9
2014
Q3
$440M Buy
1,822,786
+1,346,016
+282% +$301M 4.96% 3
2014
Q2
$106M Buy
476,770
+17,570
+4% +$3.64M 1.02% 33
2014
Q1
$94.5M Buy
+459,200
New +$91M 0.69% 49

Other funds holding AGN

Discovery Capital Management's AGN Position: Q4 2015 in Review

Discovery Capital Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 1,986,643 shares — an estimated $540M sold.

Discovery Capital Management first reported a position in AGN in Q1 2014 and held it in 7 quarters. The position peaked at $540M in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Discovery Capital Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Discovery Capital Management sold 1,986,643 Allergan plc shares in Q4 2015, an estimated $540M.
  • Discovery Capital Management first reported a position in Allergan plc in Q1 2014 and held it in 7 quarters.
  • Discovery Capital Management's Allergan plc position peaked at $540M in Q3 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Discovery Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.